Accessibility Menu
Organon & Co. Stock Quote

Organon & Co. (NYSE: OGN)

$8.91
(-0.4%)
-0.04
Price as of October 23, 2025, 12:00 p.m. ET

KEY DATA POINTS

Current Price
$8.91
Daily Change
(-0.4%) $0.04
Day's Range
$8.87 - $9.01
Previous Close
$8.94
Open
$8.91
Beta
0.91
Volume
977,755
Average Volume
3,986,317
Market Cap
2.3B
Market Cap / Employee
$8.94M
52wk Range
$8.01 - $19.05
Revenue
-
Gross Margin
0.56%
Dividend Yield
6.71%
EPS
$2.69
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Organon & Co. Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
OGN-46.36%N/AN/A-67%
S&P+14.5%+93.32%+14.09%+61%

Organon & Co. Company Info

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$1.59B-0.8%
Gross Profit$874.00M-6.9%
Gross Margin54.83%-3.6%
Market Cap$2.52B-52.7%
Market Cap / Employee$0.25M0.0%
Employees10K0.0%
Net Income$145.00M-25.6%
EBITDA$415.00M-8.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$599.00M-14.9%
Accounts Receivable$1.48B-8.2%
Inventory1.5K13.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$8.78B1.5%
Short Term Debt$115.00M1177.8%

Ratios

Q2 2025YOY Change
Return On Assets5.46%-3.2%
Return On Invested Capital18.05%-7.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$181.00M-39.7%
Operating Free Cash Flow$220.00M-33.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings3.794.485.153.60-32.50%
Price to Book34.207.798.134.61-95.82%
Price to Sales0.780.610.620.40-52.47%
Price to Tangible Book Value-0.96-0.79-0.68-0.45-55.25%
Price to Free Cash Flow TTM11.028.308.115.87-38.81%
Enterprise Value to EBITDA28.2232.2130.0626.06-11.46%
Free Cash Flow Yield9.1%12.0%12.3%17.0%63.42%
Return on Equity429.9%254.2%159.6%-
Total Debt$8.75B$9.04B$8.96B$8.90B2.77%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.